CDH
Charles D. Hyman Portfolio holdings
AUM
$1.79B
This Quarter Return
+3.15%
1 Year Return
+17.18%
3 Year Return
+36.79%
5 Year Return
+95.96%
10 Year Return
+199.47%
AUM
$783M
AUM Growth
+$783M
(+3.9%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
31.31%
Holding
161
New
15
Increased
53
Reduced
46
Closed
6
Top Buys
| 1 |
Intel
INTC
|
$2.64M |
| 2 |
FRP Holdings
FRPH
|
$2.48M |
| 3 |
RTX Corp
RTX
|
$1.63M |
| 4 |
Morgan Stanley Floating Rate non-cumulative Preferred Series A
MS.PRA
|
$1.62M |
| 5 |
Microsoft
MSFT
|
$1.53M |
Top Sells
| 1 |
EVER.PRA
EverBank Financial Corp.
EVER.PRA
|
$9.34M |
| 2 |
Johnson Controls International
JCI
|
$1.47M |
| 3 |
Bank of America
BAC
|
$631K |
| 4 |
ConocoPhillips
COP
|
$573K |
| 5 |
EVER
Everbank Financial Corp
EVER
|
$507K |
Sector Composition
| 1 | Industrials | 22.46% |
| 2 | Consumer Staples | 10.6% |
| 3 | Financials | 10.29% |
| 4 | Healthcare | 9.57% |
| 5 | Consumer Discretionary | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Opko Health
OPK
$1.1B
| $119K | 0.02% | 18,119 | – | – |
|
|
NCV
152
Virtus Convertible & Income Fund
NCV
$334M
| $93K | 0.01% | 13,400 | – | – |
|
|
NVIV
153
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $81K | 0.01% | 30,000 | – | – |
|
|
SMRT
154
DELISTED
Stein Mart Inc
SMRT
| $54K | 0.01% | +31,900 | New | +$54K |
|
|
GNMX
155
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $20K | ﹤0.01% | 15,143 | – | – |
|
|
156
Johnson Controls International
JCI
$69.9B
| – | – | -34,936 | Closed | -$1.47M |
|
157
Sonnet BioTherapeutics
SONN
$22M
| – | – | -44,444 | Closed | -$16K |
|
158
Target
TGT
$43.6B
| – | – | -3,800 | Closed | -$210K |
|
159
TotalEnergies
TTE
$137B
| – | – | -4,000 | Closed | -$202K |
|
|
EVER
160
DELISTED
Everbank Financial Corp
EVER
| – | – | -26,035 | Closed | -$507K |
|
|
EVER.PRA
161
DELISTED
EverBank Financial Corp.
EVER.PRA
| – | – | -368,425 | Closed | -$9.34M |
|